Delivery Order 75N95022D00021-75N95024F00002

Award Date 3/26/24
Potential Completion Date 3/25/27
Potential Value $2.6M
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" IDIQ contract by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The $634,385.25 award to Battelle Memorial Institute, a non-profit research and development organization, is for a 13-hour cardiovascular and pulmonary safety pharmacology study of the drug candidate HBN-1 using telemetered...
This is a $14,106,772 cost plus fixed fee delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Battelle Memorial Institute for validation of bioanalytical assays and IND-enabling GLP PD/PK toxicology studies in rats and dogs. The work is being performed under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite delivery, indefinite quantity...
This is a $4,734,236.00 delivery order under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" IDIQ contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The award is for non-clinical safety assessment of NES100 to support an analgesia indication, with a period of performance from September 18, 2020 to April 17, 2021. The prime contractor is Battelle Memorial...
This is a delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization. The $11,168,464 contract is for the manufacturing of plasmid and vector, as well as good laboratory practice (GLP) dose-escalation toxicology studies in normal rats and non-human primates. This delivery order is part of a larger...
This is a $2,743,201.00 Cost Plus Fixed Fee contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Battelle Memorial Institute, a non-profit research and development organization, for non-clinical safety assessment of VK4-116 to support human patients with severe pain disorders. The contract is a delivery order under Battelle's CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Battelle Memorial Institute, doing business as Battelle. The contract, which has a period of performance from September 17, 2020 to January 16, 2021, is for non-clinical safety studies of the compound DIPMA-AP to support its development for a chronic pain indication. The potential value of the...
This is a federal contract award to Battelle Memorial Institute (doing business as Battelle), a non-profit research and development organization, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS). The contract, valued at $460,936.39, is for non-clinical safety assessment of the compound JM-4 to support multiple sclerosis and traumatic brain injury indications. The contract is a delivery order...
This is a $792,052.00 cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for bioanalytical supports for a good laboratory practice (GLP) toxicology and biodistribution study in mini-pigs. Lovelace has extensive experience supporting federal agencies like the National Institutes of Health...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $4,288 delivery order to Battelle Memorial Institute under the Center's master IDIQ contract for CRO Support for in vitro and in vivo toxicology studies. Under the order, Battelle will perform non-clinical safety assessment of CTI-1601 to support an ataxia indication as requested by the Center. The work will be conducted in Columbus, Ohio over an 18-month period concluding in March 2019. Funding...
This is a federal contract award issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Battelle Memorial Institute, doing business as Battelle, a nonprofit research and development organization. The award, valued at $2,682,797.00, is a delivery order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The work is for pre-clinical...

This is a federal contract award from the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Battelle Memorial Institute. The $2,611,477.00 cost-plus-fixed-fee contract is for non-GLP dose-range finding and GLP toxicity studies in minipigs, as well as in vitro drug-drug interaction studies for a small peptide. The contract was awarded under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite-delivery, indefinite-quantity (IDIQ) vehicle.

The contract has no set-aside designation. Battelle has subcontracted portions of the work to QPS LLC, a minority-owned limited liability company, to conduct non-GLP dose-range finding and GLP toxicity studies, and to Inotiv, Inc., a for-profit contract research organization, to provide study execution services. The contract supports NCATS' mission in advancing translational science and biomedical research to address neurological disorders.

Generated 3/15/25, 9:48 AM